Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYS6041 in Advanced Solid Tumors
NCT07744763Phase 2Recruiting
- Sponsor
- CSPC Megalith Biopharmaceutical Co., Ltd.
- Start
- Mar 2025
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
A Phase 2 trial of SYS6041 in solid tumor, sponsored by CSPC Megalith Biopharmaceutical Co., Ltd.. Started Mar 2025; status: recruiting.
02
Drugs
SYS6041
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07744763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07744763.